Advertisement

Silent Mucus Plugs in COPD and Exacerbation Risk, With Emily Wan, MD, MPH

Published on: 

Silent mucus plugs may flag patients with COPD at greater risk of exacerbations and death, though how to manage them remains unclear.

Clinicians have long recognized mucus plugging during acute illness in chronic obstructive pulmonary disease (COPD). Only in the past 5 to 10 years have researchers begun measuring plugs on chest CT in patients in their usual state of health.

Emily Wan, MD, MPH, of VA Boston Healthcare System and Brigham and Women’s Hospital, presented a session on the burden of mucus plugging in moderate to severe COPD at the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 COPD International Conference in Philadelphia, Pennsylvania.¹ In an interview with HCPLive, she discussed how often plugs go unrecognized, what they signal about outcomes and how clinicians can respond.

How Common Are Mucus Plugs in COPD?

Mucus plugs are found on chest CT in an estimated 25% to almost 80% of people with COPD, according to Wan.

“Our best estimates are that mucus plugs are present in anywhere from 25% to almost 80% of people with COPD,” she said.

Clinicians have long been aware of plugging, Wan noted, but efforts to quantify it in people who are not acutely ill are recent.

Are Mucus Plugs on CT Linked to COPD Exacerbations and Mortality?

Mucus plugs on chest CT are associated with a greater risk of moderate to severe and severe COPD exacerbations, as well as greater mortality from any cause. Severe exacerbations are the ones Wan described as landing patients in the hospital.

At a single point in time, plugs are associated with worse lung function, more breathlessness and poorer COPD control. They are also associated with worse scores on the COPD Assessment Test and the St. George’s Respiratory Questionnaire.

Wan and colleagues examined plugs on baseline CT in 2 independent cohorts with spirometry-confirmed COPD and found an association with future moderate to severe exacerbations.² In her session, Wan reported that over 2 to 8 years of follow-up, each 1-point increase in plug score was linked to a 3% to 8% greater risk of moderate to severe exacerbations.¹

The mortality data come largely from COPDGene. Among 4,363 participants with COPD, 59.3% had no plugs, 21.8% had plugs in 1 to 2 lung segments and 18.9% had plugs in 3 or more segments.³ Mortality during follow-up was 34.0%, 46.7% and 54.1% across those groups.³

After adjustment for factors including age, smoking history, lung function, emphysema and airway wall thickness, plugs in 1 to 2 segments were associated with an adjusted hazard ratio for death of 1.15 (95% CI, 1.02 to 1.29). Plugs in 3 or more segments were associated with an adjusted hazard ratio of 1.24 (95% CI, 1.10 to 1.41).³ Wan added that emerging data suggest a possible association with cancer risk, though she described that as a direction that needs more study.

Can Patients With COPD Have Mucus Plugs Without Cough or Phlegm?

Yes. Wan said about 30% of mucus plugs seen on CT are not accompanied by chronic cough and phlegm, so patients may not know they have them. That estimate is consistent with published work showing that up to 30% of people with COPD who have plugs on CT report no cough or phlegm.⁴

In a COPDGene analysis, 1,739 of 4,363 participants with COPD had no cough or phlegm, and 627 (36%) of them had plugs on CT.⁵ After adjustment, these silent plugs were associated with a shorter 6-minute walk distance and lower resting oxygen saturation. They were also associated with lower percent predicted forced expiratory volume in 1 second (FEV1), more emphysema, thicker airway walls and greater odds of a severe exacerbation in the prior year.⁵

“My patients coming to me with chronic bronchitis, they may or may not have mucus plugs,” Wan said. “It’s not synonymous, but it is important.”

How Should Clinicians Manage Mucus Plugs in COPD?

For patients with COPD who report cough and phlegm, Wan recommends optimizing inhaled therapy and considering airway clearance techniques as an adjunct. Because most research on mucus plugs is observational, she would not target the plug itself.

“We don’t quite know what to do with those silent mucus plugs yet,” Wan said. Still, in her view, knowing a patient has plugs places them in a somewhat higher risk category.

Therapies aimed directly at plugs remain investigational in COPD. In asthma, type 2 biologics have reduced CT mucus plug scores, a topic Mario Castro, MD, of the University of Kansas, reviewed in a separate session at the conference.⁶ In COPD, the randomized, placebo-controlled AEOLUS trial is designed to evaluate the effect of dupilumab on CT mucus plugging at 24 weeks.⁷

What Does the 2027 GOLD Report Mean for Mucus Plugs in COPD?

The 2027 GOLD report, presented at the same conference, adds more on the evidence for and importance of mucus plugs in COPD. Wan, speaking before the full report’s formal release, welcomed the growing attention to mucus.

“I do think it holds promise in terms of being perhaps a future biomarker or even an intermediate kind of therapeutic end point,” she said.

Editors’ Note: Wan reports no relevant disclosures.

References
  1. Wan E. Burden of mucus plugging in patients with moderate to severe COPD. Presented at: GOLD 2026 COPD International Conference; November 5, 2026; Philadelphia, PA.
  2. Wan E, Yen A, Elalami R, et al. Airway mucus plugs on chest computed tomography are associated with exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2025;211(5):814-822. doi:10.1164/rccm.202403-0632OC
  3. Diaz AA, Orejas JL, Grumley S, et al. Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease. JAMA. 2023;329(21):1832-1839. doi:10.1001/jama.2023.2065
  4. Diaz AA. Beyond bronchodilation and airway inflammation: mucus plugs as a therapeutic target in COPD. Chest. 2025;167(1):34-36. doi:10.1016/j.chest.2024.08.017
  5. Mettler SK, Nath HP, Grumley S, et al. Silent airway mucus plugs in COPD and clinical implications. Chest. 2024;166(5):1010-1019. doi:10.1016/j.chest.2023.11.033
  6. Smith T. Mucus plug reduction with type 2 biologics: lessons for COPD. HCPLive. November 5, 2026. Accessed November 20, 2026. https://www.hcplive.com/view/mucus-plug-reduction-type-2-biologics-lessons-copd
  7. A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease (AEOLUS). German Center for Lung Research. Accessed November 20, 2026. https://dzl.de/klinische-studien/a-randomized-double-blind-placebo-controlled-study-to-evaluate-the-effect-of-dupilumab-on-airway-inflammation-through-assessments-of-mucus-plugging-and-other-lung-imaging-parameters-in-patients-with/

Advertisement
Advertisement